Navigation Links
Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
Date:5/18/2008

ment-free days, were significantly increased in the Advair group compared with the Singulair group. The incidence of adverse events was similar among all groups.

Advair Diskus combines two medications in one device to help prevent and control asthma symptoms. Asthma causes inflammation (swelling in the airways) and airway constriction (the tightening of muscles that surround the airways), and Advair contains both an inhaled corticosteroid, fluticasone propionate, to reduce inflammation; and an inhaled long-acting bronchodilator, salmeterol, to help prevent and reduce airway constriction. Advair is for people who still have symptoms on another asthma controller, or whose disease severity clearly warrants treatment with two maintenance therapies.

Important Information about Advair

Advair won't replace fast-acting inhalers for sudden symptoms and should not be taken more than twice a day. Advair contains salmeterol. In patients with asthma, medicines like salmeterol may increase the chance of asthma- related death. So Advair is not for people whose asthma is well controlled on another controller medicine. People should speak to their doctor about the risks and benefits of treating their asthma with Advair. People taking Advair should see their doctor if their asthma does not improve. Thrush in the mouth and throat may occur. People should tell their doctor if they have a heart condition or high blood pressure. Some people may experience increased blood pressure, heart rate, or changes in heart rhythm. Advair Diskus is for patients 4 years and older. For patients 4 to 11 years old, Advair Diskus 100/50 is for those who have asthma symptoms while on an inhaled corticosteroid. Advair HFA is for patients 12 years and older.

For more information about Advair please visit http://www.gsk.com.

Important Information about Flonase

For best results, use Flonase daily. Your nasal symptoms may
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
2. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
3. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
4. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer
7. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
8. New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
9. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
10. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
11. Prism Glasses Expand the View for Patients with Hemianopia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., Calif., Nov. 9 Anesiva...vember 5, 2009, it received a letter from The NASD...sdaq Hearing Panel has granted Anesiva,s request f...ubject to the condition that Anesiva shall have co...ed merger (the "Merger") contemplated by the Agree...
(Date:11/7/2009)...Nov. 7 Patients reported C1-estera...therapy in treating acute swelling attacks at any ...disorder, according to data presented today at the...munology (ACAAI) Annual Meeting. The results come ...in parallel with the ongoing, prospective, open la...
(Date:11/6/2009)...INGTON, Pa., Nov. 6 In consultatio..., McNeil Consumer Healthcare, Division of McNEIL-P...mited number of product lots of TYLENOL® Arth...inctive red EZ-OPEN CAP. McNeil is initiating the ... or taste associated with these lots that led to a...
Breaking Medicine Technology:Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 1Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 2Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 3Amgen Named Presenting Sponsor of The Dempsey Challenge 3A A Journey For Hope 56650 4New type of adult stem cells found in the prostate may be involved in prostate cancer development 56649 1New type of adult stem cells found in the prostate may be involved in prostate cancer development 56649 2Ancient oceans offer new insight into the origins of animal life 9852 1Ancient oceans offer new insight into the origins of animal life 9852 2
(Date:11/9/2009)...swire/ -- At a time when the 250,000+ eligible Med...ed about finding affordable health insurance, they...,, The Today,s Options® Preferred Provider...es a cost-effective and comprehensive alternative .... People with Medicare can choose to sign up for ...
(Date:11/9/2009)...m our current campaign finance system ,, WASHI...f Congress who noted "no" on health care reform le...illion more in campaign donations from health insu...he legislation to overhaul of the nation,s health ...oalition of campaign reform groups. ,, "The hea...
(Date:11/9/2009)...- , , WHAT: All PETCO stores nationwide wil... facilitated by specially trained in-store nutriti...at 2 p.m. During the 30-minute, work... needs of, their dogs and cats, have ...good pet nutrition, receive an assessment of their...
(Date:11/9/2009)...l and the University of Florida Proton Therapy Ins...on therapy for St. Jude patients. The announcement...to evaluate the use of proton therapy for rare bra... , Under the clinical protocol, St. Jude will re...roton Therapy Institute in Jacksonville, Fla. The ...
(Date:11/9/2009)...issue of European Urology , the official journal ...n article entitled ,Are Infertile Men Less Healthy...ontrol Survey, by Dr. Andrea Salonia et al. The co...ated with a number of medical comorbidities, as ob...Comorbidity Index. , Dr. Andrea Salonia from the...
Breaking Medicine News(10 mins):Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:'No' Votes on Health Care Bill Received $2.3 Million More from Health Insurance Industry 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:European Urology: Male factor infertility associated with comorbidities 2
... 17 /PRNewswire-FirstCall/ - CRH Medical Corporati... demand in Las Vegas it,recently hired Dr. Ronald ...lorectal Health. By adding a second physician, the... CRH Medical believes over time this can be an ex...
...tain Health to strengthen brand recognition, natio...d wellness products, BUFFALO, N.Y., Sept. 17 Mer...vider of self-funded health plans, today announced...ired Weyco in August 2006 and CBSA PERFORMAX that,...
...NA might improve treatment, researchers say , ...searchers say they,ve found a gene that plays a cr...o respond to estrogen. , The finding that transcri...y help explain differences in the effectiveness of...
...ltidisciplinary team of researchers from Columbia ...lion, five-year Program Project Grant (PPG) from t...y people with type 2 diabetes are dangerously susc...el, M.D., director of The National Heart Lung and ...
...ips MBA Offers Extensive Hospital, Financial and C..., PRINCETON, N.J., Sept. 17 GSI Securitization,I...at Michael E. Phillips,has been elected to our Boa...and finance,industry. In the Healthcare Arena: M...
...7 John Brooke, General Manager of,Billian,s Healt...telligence,will be speaking at Dreamforce ,07 Glob... Developer Conference in San Francisco this week. ... spanning industries, roles and locales. Mr. Brook...
Other Medicine News:Health News:CRH Medical expands Las Vegas operations 2Health News:Meritain Health Announces Name Change for Acquired Companies 2Health News:NIH awards $10.8M to Columbia to study connection between diabetes and heart disease 2Health News:NIH awards $10.8M to Columbia to study connection between diabetes and heart disease 3Health News:Fund Manager Joins Board of GSI Securitization Inc. 2Health News:Billian's HealthDATA GM Speaking on Dreamforce 07 Panel 2
DELFIA Platewash
8 Channel ImmunoWasher
...signed to meet the working and budgetary laborator...user to run set assays at the touch of a button. T...to wash 8 or 12 wells at a time. Reliable, compact...rfill protection, quiet operation, and minimal mai...
SkanWasher 300 (110V)
Medicine Products: